292 related articles for article (PubMed ID: 12858357)
1. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
Yousef GM; Stephan C; Scorilas A; Ellatif MA; Jung K; Kristiansen G; Jung M; Polymeris ME; Diamandis EP
Prostate; 2003 Sep; 56(4):287-92. PubMed ID: 12858357
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues.
Yousef GM; Scorilas A; Chang A; Rendl L; Diamandis M; Jung K; Diamandis EP
Prostate; 2002 May; 51(2):126-32. PubMed ID: 11948967
[TBL] [Abstract][Full Text] [Related]
3. Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer.
Stephan C; Yousef GM; Scorilas A; Jung K; Jung M; Kristiansen G; Hauptmann S; Kishi T; Nakamura T; Loening SA; Diamandis EP
J Urol; 2004 Jan; 171(1):187-91. PubMed ID: 14665873
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer.
Stavropoulou P; Gregorakis AK; Plebani M; Scorilas A
Clin Chim Acta; 2005 Jul; 357(2):190-5. PubMed ID: 15893744
[TBL] [Abstract][Full Text] [Related]
5. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
[TBL] [Abstract][Full Text] [Related]
6. Quantitative expression analysis and study of the novel human kallikrein-related peptidase 14 gene (KLK14) in malignant and benign breast tissues.
Papachristopoulou G; Avgeris M; Charlaftis A; Scorilas A
Thromb Haemost; 2011 Jan; 105(1):131-7. PubMed ID: 21057706
[TBL] [Abstract][Full Text] [Related]
7. Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer.
Sidiropoulos M; Chang A; Jung K; Diamandis EP
Br J Cancer; 2001 Aug; 85(3):393-7. PubMed ID: 11487271
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
9. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
[TBL] [Abstract][Full Text] [Related]
10. Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
Collard RL; Harya NS; Monzon FA; Maier CE; O'Keefe DS
Prostate; 2006 May; 66(7):687-95. PubMed ID: 16425203
[TBL] [Abstract][Full Text] [Related]
11. Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis.
Kishi H; Igawa M; Kikuno N; Yoshino T; Urakami S; Shiina H
J Urol; 2004 May; 171(5):1855-60. PubMed ID: 15076293
[TBL] [Abstract][Full Text] [Related]
12. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS
Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663
[TBL] [Abstract][Full Text] [Related]
13. Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.
Fuessel S; Sickert D; Meye A; Klenk U; Schmidt U; Schmitz M; Rost AK; Weigle B; Kiessling A; Wirth MP
Int J Oncol; 2003 Jul; 23(1):221-8. PubMed ID: 12792797
[TBL] [Abstract][Full Text] [Related]
14. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
[TBL] [Abstract][Full Text] [Related]
16. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
[TBL] [Abstract][Full Text] [Related]
18. Parallel overexpression of seven kallikrein genes in ovarian cancer.
Yousef GM; Polymeris ME; Yacoub GM; Scorilas A; Soosaipillai A; Popalis C; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 May; 63(9):2223-7. PubMed ID: 12727843
[TBL] [Abstract][Full Text] [Related]
19. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P
Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
[TBL] [Abstract][Full Text] [Related]
20. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer.
Stephan C; Jung K; Nakamura T; Yousef GM; Kristiansen G; Diamandis EP
Int J Urol; 2006 Mar; 13(3):238-43. PubMed ID: 16643616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
